Although Sorafenib is a kinase inhibitor with multiple targets including RTKs and RAF, its treatment did not affect the total tyrosyl phosphorylation and ERK phosphorylation in TamR cells (Figure S5), indicating that inhibition of TamR ER+ breast cancer cell growth by Sorafenib under the concentration used is not through inhibition of RTKs and RAF
Me lo noto bastante 09-09-2024 Ramn Me va genial, el sabor est muy bien
[DOI] [PMC free article] [PubMed] [Google Scholar] 2.Davies M., Faerch L., Jeppesen O.K., Pakseresht A., Pedersen S.D., Perreault L., Rosenstock J., Shimomura I., Viljoen A., Wadden T.A., et al
Evaluation of a melanocortin4 receptor (MC4R) agonist (setmelanotide) in MC4R deficiency
Ideal para piel normal a mixta
However, adipocyte Ndufs2 KO mice had reduced WAT mass, increased liver mass, visceral adipocyte hypertrophy and impaired glucose tolerance (Fig